Sjögren's syndrome associated with systemic lupus erythematosus: Clinical and laboratory profiles and comparison with primary Sjögren's syndrome
Top Cited Papers
Open Access
- 5 March 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (3) , 882-891
- https://doi.org/10.1002/art.20093
Abstract
Objective. To address the clinical, serologic, pathologic, and immunogenetic features of sicca syndrome that occurs in systemic lupus erythematosus (SLE), as well as its similarities to, and differences from, sicca syndrome that occurs in primary Sjögren's syndrome (SS). Methods. A cohort of 283 consecutive unselected SLE patients was evaluated for the presence of associated SS using the American–European classification criteria. Clinical and laboratory parameters in SLE patients with SS (SLE–SS) were compared with those in SLE patients without SS (SLE–no SS) and with a group of 86 unselected patients with primary SS. Results. SS was identified in 26 SLE patients (9.2%); the SS preceded the development of lupus in 18 of them (69.2%). Compared with the SLE–no SS group, patients with SLE–SS were significantly older, had a higher frequency of Raynaud's phenomenon, anti-Ro/SSA, anti-La/SSB, and rheumatoid factor, but had a significantly lower frequency of renal involvement, lymphadenopathy, and thrombocytopenia. Compared with the primary SS group, SLE–SS patients displayed a clinically similar sicca syndrome, but were significantly younger and had an increased frequency of perivascular infiltrates in the salivary glands associated with anticardiolipin antibodies in the serum. SLE–SS patients had a high frequency of the DRB1*0301 allele. This HLA profile distinguished the SLE–SS group from the SLE–no SS group, who had an increased frequency of DRB1*1501 and DQB1*0602 alleles, but was similar to the HLA profile of the primary SS group, who had an increased frequency of DRB1*0301. Conclusion. SLE–SS appears to constitute a subgroup of patients with distinct clinical, serologic, pathologic, and immunogenetic features, in whom SS is expressed as an overlapping entity and is largely similar to primary SS.Keywords
This publication has 31 references indexed in Scilit:
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- HLA Class II DNA Typing in a Large Series of European Patients with Systemic Lupus ErythematosusMedicine, 2002
- Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variablesAnnals of the Rheumatic Diseases, 2001
- Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromesArthritis & Rheumatism, 1999
- Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndromeLupus, 1998
- Vasculopathy of the Antiphospholipid Syndromes Revisited: Thrombosis is the Culprit and Vasculitis the ConsortLupus, 1996
- The Immunogenetic Relationship Between Anti-Ro(SS-A)/La(SS-B) Antibody Positive Sjögren's/Lupus Erythematosus Overlap Syndrome and the Neonatal Lupus SyndromeJournal of Investigative Dermatology, 1989
- Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritisThe American Journal of Medicine, 1979